Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Author: Braune Stefan   Lang M.   Bergmann A.  

Publisher: Springer Publishing Company

ISSN: 0340-5354

Source: Journal of Neurology, Vol.260, Iss.12, 2013-12, pp. : 2981-2985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next